Kenneth Rand, MD
Professor
|
|
Dept. of Pathology, Immunology and Laboratory Medicine |
Currently Involved In:
Clinical Microbiology
The research laboratory is focused on a project to use microarrays for viral discovery. In addition, we are actively studying the mechanism of synergy between daptomycin and rifampin against rifampin-resistant vancomycin-resistant E. faecium (VRE).
Sarcoidosis
A second major research focus is the search for an antigen or nucleic acid unique to sarcoidosis. Given the data using the Kveim antigen as a skin test for sarcoidosis, it seems inescapable that sarcoid tissue contains some antigenic component that is reasonably specific for the disease. Our approach involves purification of such an antigen and serological identification, as well as methods to identify associated nucleic acid.
Biotechnology Due Diligence
As start-up biotechnology companies search for venture capital to develop new technologies and products, due diligence is needed to provide an independent and objective assessment of their claims. We have the capability of evaluating both new technology and its biomedical applicability. Dr. Rand has over 30 years experience in basic biomedical research, patient care, as well as technical and medical/administrative direction of the Shands Hospital laboratory. Combining the breadth of this experience with the access to experts in all basic and clinical specialties at the University of Florida, we can provide a unique resource for the evaluation of new ideas, technologies or products.